跳至主要内容
临床试验/EUCTR2009-017351-96-BE
EUCTR2009-017351-96-BE进行中(未招募)不适用

A placebo controlled trial with Baclofen for the treatment of GERD patients with incomplete PPI response

Zleuven0 个研究点开始时间: 2009年12月3日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • 1.18 to 75 years old.
  • 2.History of GERD symptoms during PPI treatment, at least 3 times per week for 12 weeks.
  • 3.Daily intake of PPI treatment 12 weeks prior to inclusion, with at least 8 weeks of b.i.d. therapy (2*20mg of omeprazole or equivalent).
  • 4.Sexually active women of child bearing potential participating in the study must use a medically acceptable form of contraception. Medically acceptable forms of contraception include oral contraceptives, injectable or implantable methods, intrauterine devices, or properly used barrier contraception.
  • 5.Subjects must be capable of understanding and be willing to provide signed and dated written voluntary informed consent before any protocol-specific screening procedures are performed.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • 1.Endoscopic signs of severe erosive esophagitis (= grade C, Los Angeles classification) on endoscopy performed during PPI treatment in the 6 months prior to screening.
  • 2.Systemic diseases, known to affect esophageal motility.
  • 3.Surgery in thorax or in the upper part of the abdomen.
  • 4.Treatment with baclofen prior to the start of the study.
  • 5.Regular use of medications such as: anticholinergics, tricycle antidepressants.
  • 6.Significant neurological, respiratory, hepatic, renal, haematological, cardiovascular, metabolic or gastroinestinal cerebrovascular disease as judged by the investigator
  • 7.Absence of PPI intake for at least 2 consecutive days in the 2 weeks prior to the screening.
  • 8.Pregnancy or breast feeding.
  • 9.History of poor compliance. History of/or current psychiatric illness that would interfere with ability to comply with protocol requirements or give informed consent. (well-compensated depression is allowed).
  • 10.History of alcohol or drug abuse that would interfere with ability to comply with protocol requirements.

研究者

发起方
Zleuven

相似试验